01—Abstract
Summary
Summary of the 10-K filed February 27, 2012. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. ("Omega") is a self-administered REIT that provides lease or mortgage financing to operators of skilled nursing facilities (SNFs) and, to a lesser extent, assisted living and other healthcare facilities.
As of December 31, 2011, its portfolio consisted of 438 healthcare facilities in 35 states operated by 51 third-party operators, with gross investments of approximately $2.8 billiona. Total revenue rose to $292.2 million in 2011 from $258.3 million in 2010, and net income available to common stockholders was $47.5 million, or $0.46 per diluted share, compared with $49.4 million, or $0.52, in 2010. Funds from operations available to common stockholders was $172.5 million, compared with $134.1 million in 2010.
The company completed approximately $334 millionb of new investments in the fourth quarter of 2011, including purchase/leaseback transactions with new operators, a $92.0 million first mortgage loan with affiliates of Ciena Healthcare Management, and a $28.0 million term loan with affiliates of Signature. Results were weighed by a $26.3 million impairment provision, largely a $24.4 million charge on four closed Connecticut facilities. Debt totaled about $1.6 billion, representing approximately 63.8% of total capitalization, and the company reported $272.5 million outstanding under its $475 million unsecured 2011 Credit Facility.
The filing highlights concentration and regulatory risk. Approximately 37% of real estate investments were operated by Sun Healthcare, CommuniCare, Airamid and Signature, and management expects operators to absorb moderate reimbursement cuts, though the filing notes Medicare SNF reimbursement reductions of $3.87 billionc (11.1%) for fiscal 2012 and a 2% automatic Medicare cut from 2013 under the Budget Control Act of 2011. The Board raised the quarterly common dividend to $0.41 per share in January 2012, and the company had $97.1 million remaining under its $100 million stock repurchase authorization.
02—Key points
Key Highlights
- Portfolio of 438 healthcare facilities in 35 states operated by 51 third-party operators, with gross investments of approximately $2.8 billion at December 31, 2011.
- Total revenues increased to $292.2 million in 2011 from $258.3 million in 2010; net income available to common stockholders was $47.5 million ($0.46 per diluted share) versus $49.4 million ($0.52) in 2010.
- Funds from operations available to common stockholders rose to $172.5 million from $134.1 million in 2010.
- Approximately $334 million of new investments were completed in Q4 2011, including the $92.0 million Ciena mortgage and the $28.0 million Signature term loan.
- Impairment provision of $26.3 million in 2011, primarily a $24.4 million charge on four closed Connecticut facilities.
- Concentration risk: Sun Healthcare, CommuniCare, Airamid and Signature together operated approximately 37% of real estate investments.
- Common dividend increased to $0.41 per share for the quarter paid February 15, 2012; $97.1 million remained under the $100 million stock repurchase program.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2011filed February 27, 2012Financial Statements
FY2011 against FY2010
| Line item | FY2011FY2010 | Change |
|---|---|---|
| Operating Expenses | $154.41M$109.38M | +41.2% |
| Operating Income | $137.79M$148.94M | −7.5% |
| Interest Expense | $81.15M$67.34M | +20.5% |
| Net Income | $52.61M$58.44M | −10.0% |
| EPS (Basic) | $0.46$0.52 | −11.5% |
| EPS (Diluted) | $0.46$0.52 | −11.5% |
| Shares Outstanding (Basic) | 102.12M94.06M | +8.6% |
| Shares Outstanding (Diluted) | 102.18M94.24M | +8.4% |
05—Questions
Frequently Asked Questions
How did Omega's revenue and earnings change in 2011?
Total revenue rose to $292.2 million from $258.3 million, an increase of $33.9 million, driven mainly by rental income from the 2010 CapitalSource acquisitions. Net income available to common stockholders fell to $47.5 million ($0.46 per diluted share) from $49.4 million ($0.52), reflecting a $26.3 million impairment provision, higher depreciation and amortization of $100.3 million, and higher interest expense.
What is the main reimbursement risk facing Omega's operators?
A significant portion of operator revenue comes from Medicare and Medicaid. The filing describes a Medicare SNF reimbursement reduction of $3.87 billion (11.1%) for fiscal 2012 after a recalibration and market basket update, and automatic spending cuts including a likely 2% cut to Medicare providers beginning in 2013. Management states that operator coverage ratios are adequate and that operators can absorb moderate reductions, but significant limits on reimbursement could have a material adverse effect.
How concentrated is Omega's tenant base?
As of December 31, 2011, approximately 37% of real estate investments were operated by Sun Healthcare (8%), CommuniCare (12%), Airamid (9%) and Signature (8%). No other operator represented more than 6% of investments. For 2011, CommuniCare generated about $38.6 million (13%) and Sun about $33.6 million (11%) of revenues from operations.
What was Omega's capital structure and liquidity position at year-end 2011?
Total assets were $2.6 billion, stockholders' equity was $0.9 billion, and debt was $1.6 billion, representing approximately 63.8% of total capitalization. The company had $272.5 million drawn under its $475 million 2011 Credit Facility, leaving $202.5 million of availability. Management believes liquidity is more than adequate to fund operations, debt service and dividends through the next twelve months.
What capital actions did Omega take in 2011?
Omega redeemed all 8.375% Series D Preferred Stock on March 7, 2011 at $25.21519 per share, funded largely with approximately $103 million borrowed under its 2010 Credit Facility. It exchanged $575 million of 6.75% Senior Notes due 2022 into registered notes, replaced its 2010 Credit Facility with the $475 million 2011 Credit Facility, and repurchased 183,310 common shares at $15.96 per share under a $100 million authorization.
06—Continue